Effects of enalapril in cats with pressure overload-induced left ventricular hypertrophy

Journal of Feline Medicine and Surgery

Volumn 9, Issue 1, 2007, Pages 29-35

  Ishikawa, Yumi ^a   Uechi, Masami ^a,b   Hori, Yasutomo ^a   Takashi Ebisawa, ^a   Yamano, Shigeki ^a   Enomoto, Youko ^a   Jun Ugai, ^a  

^a KITASATO UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANIMAL; ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CAT; CAT DISEASE; CLINICAL TRIAL; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAT DISEASES; CATS; ENALAPRIL; HYPERTROPHY, LEFT VENTRICULAR; MODELS, ANIMAL; VENTRICULAR FUNCTION, LEFT;

FELIDAE;

EID: 33846477832     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2006.02.008     Document Type: Article

References (21)

1. Agras P.I., Derbent M., Ozcay F., Baskin E., Turkoglu S., Aldemir D., Tokel K., and Saatci U. Effect of congenital heart disease on renal function in childhood. Nephron Physiology 99 (2005) 10-15
2. Atkins C.E., Brown W.A., Coats J.R., Crawford M.A., DeFrancesco T.C., Edwards J., Fox P.R., Keene B.W., Lehmkuhl L., Luethy M., Meurs K., Petrie J.P., Pipers F., Rosenthal S., Sidley J.A., and Straus J. Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. Journal of American Veterinary Medical Association 221 (2002) 654-658
3. Berl T., and Schrier R.W. Disorder of water metabolism. In: Schrier R.W. (Ed). Renal and Electrolyte Disorders. 4th edn (1992), Little, Brown and Company, Boston 1-88
4. Borghi C., Bacchelli S., Esposti D.D., Bignamini A., Magnani B., and Ambrosioni E. Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. American Journal of Hypertension 12 (1999) 665-672
5. Chockalingam A., Venkatesan S., Subramaniam T., Jagannathan V., Elangovan S., Alagesan R., Gnanavelu G., Dorairajan S., Krishna B.P., and Chockalingam V. Symptomatic cardiac obstruction - pilot study of enalapril in aortic stenosis. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction - Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). American Heart Journal 147 (2004) E19
6. COVE Study Group. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. Journal of Veterinary Internal Medicine 9 (1995) 243-252
7. Cox N.L., Abdul-Hamid A.R., and Mulley G.P. Why deny ACE inhibitors to patients with aortic stenosis?. Lancet 352 (1998) 111-112
8. Dzau V.J. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Archives of Internal Medicine 153 (1993) 937-942
9. Ettinger S.J., Benitz A.M., Ericsson G.F., Cifelli S., Jernigan A.D., Longhofer S.L., Trimboli W., and Hanson P.D. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-term Investigation of Veterinary Enalapril (LIVE) Study Group. Journal of American Veterinary Medical Association 213 (1998) 1573-1577
10. Fouad-Tarazi F.M., and Liebson P.R. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension. Hypertension 9 (1987) II65-II68
11. Grandi A.M., Venco A., Barzizza F., Casadei B., Marchesi E., and Finardi G. Effect of enalapril on left ventricular mass and performance in essential hypertension. American Journal of Cardiology 63 (1989) 1093-1097
12. Grimm D., Kromer E.P., Bocker W., Bruckschlegel G., Holmer S.R., Riegger G.A., and Schunkert H. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition. Journal of Hypertension 16 (1998) 1345-1355
13. Manual of ACE color for in vitro diagnostic use. A reagent for measurement of angiotensin converting enzyme (ACE). Fujirebio Inc.
14. Morimoto T., Gandhi T.K., Fiskio J.M., Seger A.C., So J.W., Cook E.F., Fukui T., and Bates D.W. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. Journal of Evaluation in Clinical Practice 10 (2004) 499-509
15. Nelson R.W., Couto C.G., Bunch S.E., Lappin M.R., Grauer G.F., Taylor S.M., Hawkins E.C., Ware W.A., Johnson C.A., and Willard M.D. Overview of heart failure management. Small Animal Internal Medicine. 2nd edn (1998), Mosby, St. Louis pp. 52-54
16. Rush J.E., Freeman L.M., Brown D.J., and Smith Jr. F.W. The use of enalapril in the treatment of feline hypertrophic cardiomyopathy. Journal of American Animal Hospital Association 34 (1998) 38-41
17. Schunkert H., Dzau V.J., Tang S.S., Hirsch A.T., Apstein C.S., and Lorell B.H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. Journal of Clinical Investigation 86 (1990) 1913-1920
18. Uechi M., Imamoto S., and Ishikawa Y. Dose-dependent inhibition of angiotensin converting enzyme by enalapril in cats. Journal of Veterinary Medical Science 64 (2002) 385-387
19. Uechi M., Nogami Y., Terui H., Nakayama T., Ishikawa R., Wakao Y., and Takahashi M. Evaluation of urinary enzymes in dogs with early renal disorder. Journal of Veterinary Medical Science 56 (1994) 555-556
20. Weir M.R., and Dzau V.J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. American Journal of Hypertension 12 (1999) 205S-213S
21. Zee R.Y., Rao V.S., Paster R.Z., Sweet C.S., and Lindpaintner K. Three candidate genes and angiotensin-converting enzyme inhibitor-related cough: a pharmacogenetic analysis. Hypertension 31 (1998) 925-928